Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone pharmacodynamics in healthy male subjects
NCT03196557Phase 1Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2008
- Primary completion
- May 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Inflammatory Disorders comparing Prednisolone Arm with Placebo Arm (2 arms). Primary endpoints: Interleukin 1 beta up to 32 days, Tumor necrosis factor-alpha up to 32 days and 16 more. Started Mar 2008; status: completed.
02
Drugs
prednisolone
03
Conditions
Inflammatory Disorders
Beyond the preview
Go deeper on NCT03196557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03196557.